John A. Kosteva

1.0k citations
12 papers · 496 indexed · 1 hit paper · h-index 6

John A. Kosteva

11 papers receiving 493 citations

Hit Papers

Pretreatment neutrophil-to-lymphocyte ratio as a marker o...3872017202620202023100200300

Peers

John A. Kosteva
Comparison fields: 5 of 41
  • Oncology 435
  • Pulmonary and Respiratory Medicine 204
  • Immunology 77
  • Cancer Research 52
  • Otorhinolaryngology 12
Replace Iveta Kudaba with:
Iveta Kudaba Latvia
Audrey Simonaggio France
Paloma Martín-Martorell Spain
Sehhoon Park South Korea
Guoqiang Wang China
Matías Chacón Argentina
Munehiro Ito Japan
Jeffrey M. Lemons United States
Jihane Boustani France
Erjiang Tang China
John A. Kosteva relative to Iveta Kudaba Latvia Iveta Kudaba's profile →
Citations per field
00.5×10×15×20×23×
Iveta Kudaba · 1×
Citations per year

Countries citing papers authored by John A. Kosteva

Since Specialization
Citations

This map shows the geographic impact of John A. Kosteva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Kosteva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Kosteva more than expected).

Fields of papers citing papers by John A. Kosteva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Kosteva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Kosteva. The network helps show where John A. Kosteva may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John A. Kosteva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John A. Kosteva Line = papers co-authored together John A. Kosteva links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 20250
2 20242
3 202322
4 20232
5 20221
6 202213
7 20179
8 20174
9
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancerbreakdown →
2017387
10 20172
11 201626
12 200828

About John A. Kosteva

John A. Kosteva is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 12 papers that have together received 496 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Genomics and Diagnostics (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Advanced Breast Cancer Therapies (1 paper) and Radiomics and Machine Learning in Medical Imaging (1 paper). The work is most often cited by research in Oncology (435 citations), Pulmonary and Respiratory Medicine (204 citations) and Immunology (77 citations). John A. Kosteva has collaborated with scholars based in United States. Frequent co-authors include Corey J. Langer, Stephen Bagley, Tracey L. Evans, Charu Aggarwal, Roger B. Cohen, Peter Gabriel, Jeffrey C. Thompson, Evan Alley, Faith Mutale and Christine Ciunci. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026